Piper Sandler reiterates On Holding stock rating on innovation outlook

Piper Sandler reiterated Overweight on On Holding with a $45 target, expecting Q3 FY2026 sales to slightly beat guidance of approximately 17% constant-currency growth, while Street estimates are 18%. Piper sees potentially softer DTC sales than the Street’s 32% estimate but stronger wholesale results, and expects management to narrow the FY2026 sales-growth range of 20%–23%; On reports results November 10. Analyst views are mixed, with targets ranging from Jefferies’ $20 Underperform to Piper’s $45 Overweight, and Stifel flagged possible China-related risk from a social-media controversy.

Analysis

ONON | Earnings setup: mix matters more than the headline beat. A wholesale-led result could validate product demand, but would be a lower-quality signal if DTC weakens: it would leave less direct evidence of full-price consumer pull and could make channel inventory and later reorder rates the key checks. Do not extrapolate a single quarter’s channel mix into structural margin deterioration without evidence on promotions and gross margin.

The near-term risk is expectation asymmetry: buy-side positioning may already allow for a slight beat, while the Street’s higher growth bar and the broad implied Q4 guidance range leave room for disappointment. Guidance narrowing toward high-teens/low-20s growth would reduce uncertainty; the actual sales mix, gross margin, and expense trajectory should determine whether that is investable. Higher marketing and selling expense is a competing explanation for growth that does not translate into earnings leverage.

Over 1–3 months, track DTC trends, wholesale reorder behavior, and management’s Q4 framing. Over 6–18 months, innovation-led growth is plausible but remains a thesis, not proof: persistent DTC softness or rising selling costs would weaken the premium-growth multiple case. The China ambassador controversy is a watch item; absent measurable demand or guidance impact, do not price it as a fundamental impairment.

Contrarian read: the debate is not simply beat versus miss, but whether demand quality supports the growth narrative. With mixed analyst views and no verified options pricing or positioning data supplied, a pre-earnings directional bet has poor evidentiary support.

Key Decisions for Investors

• Avoid initiating a large directional position immediately ahead of the November 10 report; the stated setup has meaningful event risk, and the supplied information does not establish whether options adequately price it.
• Post-earnings, consider a staged long only if management narrows Q4 guidance toward high-teens/low-20s growth and reports evidence that DTC demand and wholesale sell-through are both holding up. Scale only after checking gross margin and selling-expense commentary.
• Treat a wholesale-led beat with weaker DTC as a watch, not an automatic buy: seek confirmation in reorder trends and subsequent-quarter guidance before underwriting sustained demand.
• Falsify the constructive thesis if Q4 guidance implies growth near the low end of the stated range, DTC weakness persists, or selling costs rise without corresponding earnings support. Reassess the China risk only if the company or subsequent results indicate a measurable commercial impact.